San Diego-centered Viking Therapeutics marked alone as a serious competitor inside the weight loss drug market in February immediately after revealing promising info from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As well as in March the